ARA.TO vs. CRVS

Last updated Jun 9, 2026

ARA.TO (Aclara Resources Inc.) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. ARA.TO operates in Other Industrial Metals & Mining (Basic Materials), while CRVS operates in Biotechnology (Healthcare). Over the past 3 years, ARA.TO returned 106.55%/yr vs 48.13%/yr for CRVS. At a 0.07 correlation, their price movements are largely independent.

Performance

ARA.TO vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Aclara Resources Inc. (ARA.TO) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

ARA.TO is traded in CAD, while CRVS is traded in USD. To make them comparable, the CRVS values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, ARA.TO achieves a 95.83% return, which is significantly higher than CRVS's 47.45% return.

ARA.TO

• 1D: 0.71%
• 1M: -14.72%
• YTD: 95.83%
• 6M: 69.20%
• 1Y: 345.26%
• 3Y*: 106.55%
• 5Y*: —
• 10Y*: —

CRVS

• 1D: 0.55%
• 1M: -26.81%
• YTD: 47.45%
• 6M: 31.29%
• 1Y: 190.96%
• 3Y*: 48.13%
• 5Y*: 35.70%
• 10Y*: -0.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARA.TO vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ARA.TO Aclara Resources Inc.	95.83%	380.00%	-10.00%	56.25%	-77.78%	-10.00%
CRVS Corvus Pharmaceuticals, Inc.	47.45%	37.35%	229.72%	102.13%	-62.50%	-15.50%

Correlation

The correlation between ARA.TO and CRVS is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (All Time) Calculated using the full available price history since Dec 13, 2021	0.07

Fundamentals

Market Cap ARA.TO : CA$932.94M CRVS : $1.00B
EPS ARA.TO : -CA$0.05 CRVS : -$0.53
PB Ratio ARA.TO : 6.15 CRVS : 4.17
Total Revenue (TTM) ARA.TO : CA$0.00 CRVS : $0.00
Gross Profit (TTM) ARA.TO : -CA$1.03M CRVS : -$26.00K
EBITDA (TTM) ARA.TO : -CA$9.35M CRVS : -$47.43M

Return for Risk

ARA.TO vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARA.TO

ARA.TO Risk / Return Rank: 93
ARA.TO Sharpe Ratio Rank: 96
ARA.TO Sortino Ratio Rank: 92
ARA.TO Omega Ratio Rank: 89
ARA.TO Calmar Ratio Rank: 95
ARA.TO Martin Ratio Rank: 92

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 74
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARA.TO vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aclara Resources Inc. (ARA.TO) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARA.TO	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	3.11	1.06	+2.05
Sortino ratio: Return per unit of downside risk	3.32	4.28	-0.96
Omega ratio: Gain probability vs. loss probability	1.40	1.48	-0.08
Calmar ratio: Return relative to maximum drawdown	6.45	3.42	+3.03
Martin ratio: Return relative to average drawdown	13.69	7.54	+6.15
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARA.TO vs. CRVS - Sharpe Ratio Comparison

The current ARA.TO Sharpe Ratio is 3.11, which is higher than the CRVS Sharpe Ratio of 1.06. The chart below compares the historical Sharpe Ratios of ARA.TO and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ARA.TO	CRVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.11	1.06	+2.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.27	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.00	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	-0.02	+0.28

Drawdowns

ARA.TO vs. CRVS - Drawdown Comparison

The maximum ARA.TO drawdown since its inception was -84.38%, smaller than the maximum CRVS drawdown of -96.89%. Use the drawdown chart below to compare losses from any high point for ARA.TO and CRVS.

Drawdown Indicators

	ARA.TO	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	-84.38%	-96.89%	+12.51%
Max Drawdown (1Y) Largest decline over 1 year	-53.93%	-56.23%	+2.30%
Max Drawdown (3Y) Largest decline over 3 years	-53.93%	-69.82%	+15.89%
Max Drawdown (5Y) Largest decline over 5 years	—	-91.90%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-96.89%	—
Current Drawdown Current decline from peak	-18.97%	-55.99%	+37.02%
Average Drawdown Average peak-to-trough decline	-57.14%	-69.49%	+12.35%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.37%	25.45%	-0.08%

Volatility

ARA.TO vs. CRVS - Volatility Comparison

The current volatility for Aclara Resources Inc. (ARA.TO) is 21.67%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.75%. This indicates that ARA.TO experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARA.TO	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.67%	23.75%	-2.08%
Volatility (6M) Calculated over the trailing 6-month period	63.42%	111.86%	-48.44%
Volatility (1Y) Calculated over the trailing 1-year period	111.97%	180.94%	-68.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.47%	131.41%	-39.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	91.47%	111.37%	-19.90%

Dividends

ARA.TO vs. CRVS - Dividend Comparison

Neither ARA.TO nor CRVS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ARA.TO and CRVS in my portfolio?

ARA.TO and CRVS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.